Facial Rejuvenation
6
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by Fotona 4d 2940 Nm Laser
Research Leaders
9 sponsors active, led by Mesoestetic Pharma Group S.L.
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (6)
Unipolar Radiofrequency Treatment Combined With SkinCeuticals A.G.E. Ultra Cream for Facial Rejuvenation
Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation
Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy
Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation
A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation
Platelet Rich Therapy for Facial Rejuvenation
Research Network
Common Treatments
- Fotona 4d 2940 Nm Laser1
- Fotona 4d 1064 Nm Laser1
- Right Face Ageleft Face Control1
- Left Face Ageright Face Control1
- 755nm Laser With Cap Array1
Active Sponsors
- Mesoestetic Pharma Group S.L.2
- First Hospital of China Medical University1
- Air Force General Hospital of the PLA1
- Beijing Artemis Medical Beauty Clinic1
- xjpfW1
Top Investigators
Cynosure, Inc.
Medical Affairs Director
NYU Langone Health
Dermatology Derpartment of Xijing Hospital
Medical Center Asklepii" OOD